Therapeutic doses of niacin for lowering cholesterol range from 500 mg to 2,000 mg per day for extended-release forms, and up to 3,000 mg per day for immediate-release forms. At these doses, niacin can raise HDL (good) cholesterol by 10% to 30%, lower LDL (bad) cholesterol by 10% to 25%, and reduce triglycerides by 20% to 50%. These are far higher than the daily recommended intake of niacin for general health (14–16 mg), and they come with significant side effects that have shifted how doctors view this treatment.
Doses That Actually Move Cholesterol Numbers
The American College of Cardiology and American Heart Association have outlined two dosing approaches. For extended-release niacin, the starting dose is 500 mg per day, typically taken at bedtime. After four weeks, the dose increases to 1,000 mg per day, with a maximum of 2,000 mg per day reached over four to eight weeks. For immediate-release niacin, the starting point is 100 mg three times a day, gradually increased to a maximum of 3,000 mg per day split into two or three doses.
The gradual increase matters. Starting at full dose almost guarantees intense flushing and stomach upset, which is the main reason people abandon treatment. The slow titration lets your body adjust and makes side effects more manageable.
How Niacin Affects Your Lipid Profile
Niacin works differently from statins. It acts on fat cells by triggering a receptor that slows the release of fatty acids into your bloodstream. With fewer fatty acids reaching the liver, the liver produces less of the particles that carry triglycerides and LDL cholesterol. This is also why niacin is one of the few treatments that meaningfully raises HDL cholesterol, something statins don’t do well.
The size of the effect depends on the dose and formulation. Sustained-release forms tend to lower triglycerides by 10% to 30%, while immediate-release niacin can cut them by 20% to 50%. Both forms raise HDL and lower LDL within the ranges mentioned above, though the response varies from person to person.
“Flush-Free” Niacin Does Not Work
Many supplements sold as “flush-free” or “no-flush” niacin contain a compound called inositol hexanicotinate rather than nicotinic acid. In a head-to-head comparison, inositol hexanicotinate performed no better than placebo for improving cholesterol, triglycerides, or any lipid measure. Testing showed the compound wasn’t even absorbed into the bloodstream in meaningful amounts. Only nicotinic acid, the form that causes flushing, has any evidence of lipid-lowering effects. If you’ve been taking flush-free niacin supplements expecting cholesterol benefits, they aren’t doing anything.
Why Doctors Rarely Recommend Niacin Now
Despite niacin’s ability to improve cholesterol numbers on paper, two large clinical trials changed the conversation. The AIM-HIGH trial randomized over 3,400 patients already on statins to receive either added niacin (1,500–2,000 mg/day) or placebo. After three years, there was no difference in heart attacks, strokes, or cardiovascular deaths between the groups. The even larger HPS2-THRIVE trial followed more than 25,000 patients for nearly four years and found the same result: niacin added to statin therapy did not reduce major cardiovascular events.
Worse, the HPS2-THRIVE trial showed an 8.7% absolute increase in serious adverse events in patients taking niacin, including a significant rise in muscle damage. One subgroup analysis from AIM-HIGH did find benefit in patients with both very high triglycerides (200 mg/dL or above) and very low HDL (below 32 mg/dL), cutting their event rate from 25% to about 17%. But for the broader population, the evidence was discouraging.
The 2026 ACC/AHA guidelines now state that niacin “should generally be avoided due to poor tolerability and adverse effects” and is not recommended for routine use alongside statin therapy. It’s considered a last-line option only for severe cases of high triglycerides when other treatments have failed.
Side Effects at Therapeutic Doses
Flushing is the most common side effect and the one most people notice first. It feels like a sudden warmth and redness across the face, neck, and chest, sometimes with itching or tingling. It’s more intense with immediate-release niacin than with extended-release forms. Taking the dose at bedtime and taking a low-dose aspirin 30 minutes beforehand can reduce the intensity, and flushing tends to diminish after several weeks of consistent use.
The more serious concerns are metabolic. High-dose niacin increases fasting blood sugar by about 4% to 5%, and post-meal glucose spikes can rise by 23% to 24%. At very high doses (up to 4,500 mg/day), mean blood glucose can climb by 16%. This makes niacin particularly problematic if you have diabetes or prediabetes. It also raises uric acid levels, which can trigger gout in susceptible individuals.
Liver toxicity is another risk, particularly with older sustained-release formulations. Extended-release niacin was designed to reduce this risk, and while some liver enzyme elevations still occur, irreversible liver damage has not been documented with the extended-release form. Regular blood work to monitor liver function and blood sugar is standard during treatment.
Who Might Still Benefit
Niacin occupies a narrow space in cholesterol management today. It may still be considered for people who cannot tolerate statins and have no better alternatives, or for those with severely elevated triglycerides that haven’t responded to other treatments. The subgroup data from AIM-HIGH suggest that people with the specific combination of high triglycerides and very low HDL may see real cardiovascular benefit beyond what statins provide alone. Outside of those situations, the risk-to-benefit ratio generally doesn’t favor niacin over modern alternatives like newer cholesterol-lowering medications that have proven cardiovascular benefits in large trials.